Stock Analiz

AbbVie Inc. (ABBV) stock forecast and price target

Price $295.03 · data as of November 13, 2026

12-month price target

Average target$311.81
Upside / downside+5.7%
Analysts26
ConsensusBuy
Low $237.00Average $311.81High $350.00

Gold marker: average target · white marker: today’s price ($295.03)

Analyst ratings

Strong buy 7Buy 16Hold 5Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$13.98+39.8%$67.8B
Next fiscal year
ends December 31, 2027
$16.20+15.8%$73.9B
Next quarter
ends December 31, 2026
$3.88+43.1%$18.4B
Quarter after
ends March 31, 2027
$3.44+29.7%$16.4B

Consensus of the analysts covering AbbVie, updated daily. In the last 30 days 6 estimates were raised and 18 lowered.

Our model vs. Wall Street

Analysts see 5.7% upside over 12 months. Our discounted cash flow model with moderate assumptions puts AbbVie’s intrinsic value about 20% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the AbbVie stock price target?

The average 12-month target from 26 analysts is $311.81, 5.7% above the current price of $295.03 Targets range from $237.00 to $350.00.

Is AbbVie a buy according to analysts?

The consensus rating is “Buy” (7 strong buy, 16 buy, 5 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is AbbVie expected to earn?

Analysts expect EPS of $13.98 for the fiscal year ending December 31, 2026 and $16.20 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.